Navigation Links
Bone marrow cells migrate to tumors and can slow their growth
Date:10/7/2011

Philadelphia, PA, October 6, 2011 Bone marrow-derived cells (BMDCs) participate in the growth and spread of tumors of the breast, brain, lung, and stomach. To examine the role of BMDCs, researchers developed a mouse model that could be used to track the migration of these cells while tumors formed and expanded. Their results, published in the November issue of The American Journal of Pathology, strongly suggest that more effective cancer treatments may be developed by exploiting the mechanism by which bone marrow cells migrate to tumors and retard their proliferation.

"Our results provide an excellent in vivo experimental model where the temporal dynamics of tumor-infiltrating BMDCs may be monitored in an immunocompetent host and novel therapies targeting BMDCs for the inhibition of tumor progression may be investigated," commented lead investigator Wafik S. El-Deiry, MD, PhD, Professor and Chief, Hematology/Oncology Division at the Penn State Hershey Medical Center and Associate Director for Translational Research at the Penn State Hershey Cancer Institute. "In the future, it may be possible to use specific identified tumor-infiltrating BMDCs to deliver therapeutic cargo."

A first group of mice expressing a fluorescence gene served as donors of the bone marrow cells. A second group of mice, whose marrow had been destroyed by radiation, were injected with the donated fluorescent bone marrow. The transplanted bone marrow cells were allowed to proliferate for 8 weeks. Then, colon cancer cells were injected into the same mice and tumors formed over the next 3 weeks.

Monitoring tumor growth by optical imaging, researchers found that the tumors contained numerous types of BMDCs. Notably they also found that tumor growth is reduced in animals that received the bone marrow transplants, compared with untransplanted host mice.

According to the authors, cancer has long been viewed as a disease in which transformed cells grow an
'/>"/>

Contact: David Sampson
ajpmedia@elsevier.com
215-239-3171
Elsevier Health Sciences
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Drug dramatically reduces nausea and vomiting in bone marrow transplant patients
2. HIV Hides Out in Bone Marrow Cells
3. University of Michigan scientists discover bone marrow can harbor HIV-infected cells
4. Fewer platelets could be used for some cancer and bone-marrow transplantation patients
5. Autologous Bone Marrow Stem Cells Transplant into Parkinson's Disease Patients is Safe and May Improve Their Quality of Life
6. Vertebroplasty: Integral to treating back pain in blood marrow cancer patients
7. Bone Marrow Cancer Patients May Benefit From Drug Combo
8. Scripps Blood & Marrow Transplant Program Celebrates 30th Anniversary of Providing Life-Saving Care
9. African-Americans and women are less likely to undergo bone marrow transplantation
10. Mount Sinai discovers bone marrow plays critical role in enhancing immune response to viruses
11. Effective inducing systems of hepatic differentiation from bone marrow mesenchymal stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... CA (PRWEB) August 31, 2014 Kicking ... kicking coach Matt Nelson of Matt Nelson Kicking Academy ... business, and on being a National Camp Series (NCS) ... of HustedKicking.com. , "Matt Nelson is another high quality ... many attributes to coaching. He is an outstanding ...
(Date:8/31/2014)... August 31, 2014 This September, ... California State Library, celebrates 30 years of changing ... Since its inception, California’s Library Literacy Services has ... learn to read and write. , To mark ... the state is launching a month-long awareness campaign ...
(Date:8/31/2014)... 2014 With the NCAA set to ... hosted an interview with Yale University Associate Athletic Director ... Yale’s approach to ensuring student-athlete experience that is consistent ... highlighted a number of key factors that contribute to ... critical factor in creating this culture seems simple at ...
(Date:8/31/2014)... 31 August 2014: Renal denervation seems to be more ... hypertension when it includes accessory renal arteries, according to ... Schmiedel from Germany. , Dr Schmiedel said: "More than ... is defined as blood pressure (BP) greater than 140/90 ... hypertension (rHTN) and are unable to reduce BP below ...
(Date:8/31/2014)... Barcelona, Spain Sunday 31 August 2014: Drinking tea ... 131 000 people presented at ESC Congress today by ... "If you have to choose between tea or coffee ... are important components of our way of life. Their ... the past with sometimes divergent results. We investigated the ...
Breaking Medicine News(10 mins):Health News:MichaelHusted.com Features an Interview with Matt Nelson of Matt Nelson Kicking Academy on His Role as a Kicking Coach and on Becoming a National Camp Series Associate 2Health News:MichaelHusted.com Features an Interview with Matt Nelson of Matt Nelson Kicking Academy on His Role as a Kicking Coach and on Becoming a National Camp Series Associate 3Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 2Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 3Health News:Renal denervation more successful when it includes accessory arteries 2Health News:Drinking tea reduces non-CV mortality by 24 percent 2Health News:Drinking tea reduces non-CV mortality by 24 percent 3
... ARLINGTON, Va., Nov. 16 Acknowledging that their results ... in the International Journal of Andrology nevertheless attempt to link ... to maternal exposure to phthalates. The researchers, led by ... previous, and much publicized, study of phthalate exposure to evaluate ...
... , SOUTH SAN FRANCISCO, Calif., Nov. 15 ... Company will hold a teleconference and webcast at 8:00 a.m. Eastern ... Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse) trial of ... Conference Call and Webcast Information , To participate ...
... 15 The World Champion New York Yankees ... at New York Blood Center,s (NYBC) Biennial Chairman,s Dinner this ... The event is chaired by William J. Mullaney, MetLife ... the opportunity to honor these two outstanding supporting organizations as ...
... ... its intention to begin the drug registration process in Brazil and Colombia for its ... United States for the treatment of moderate to severe (Stage 2) chronic pain. ... Plantation, FL (Vocus) ...
... , ... from the RecordAF,registry (REgistry on Cardiac rhythm disORDers assessing ... Sessions of the,American Heart Association, show that in recently ... rhythm-control strategy,provides better short term control of the arrhythmia ...
... when new lead is needed in heart devices, ... -- Replacing or adding wiring increases the risk ... replace a pacemaker or other heart rhythm-stabilizing device, ... complication rates among patients enrolled in the REPLACE ...
Cached Medicine News:Health News:Swan Study Authors Note Results 'Not Straightforward' 2Health News:Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer 2Health News:World Champion New York Yankees, BNY Mellon to be Honored as New York Blood Center 'Champions of Life' 2Health News:Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever 2Health News:Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever 3Health News:Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever 4Health News:First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes 2Health News:First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes 3Health News:First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes 4Health News:First Global Atrial Fibrillation Registry, RecordAF, Shows Rhythm-Control Strategy With Current Therapies Achieves Improved Disease Control but not Clinical Outcomes 5
(Date:8/29/2014)... N.C. , Aug. 29, 2014 The ... of regulatory and marketplace changes. CI leaders who adjust ... In a new Best Practices, LLC study ... of actionable insights, including: - Use secondary ... than primary research - Internal staff who ...
(Date:8/29/2014)... , Aug. 29, 2014 Pomerantz LLP has ... or the "Company") (NASDAQ: EDAP ) and ... United States District Court, Southern District of ... on behalf of a class consisting of all persons ... 2013 and July 30, 2014, inclusive (the "Class Period"). This ...
(Date:8/29/2014)...   Mast Therapeutics, Inc. (NYSE MKT: ... Santosh Vetticaden, Chief Medical Officer and Senior Vice ... reasons, in mid-September.  Edwin L. Parsley , ... which Mast acquired earlier this year, will assume ... Chief Medical Officer.  Dr. Parsley previously was with ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4
... Calif., April 8, 2011 Amgen (NASDAQ: ... the expansion of its operations in Brazil, including the ... has also agreed to reacquire rights in Brazil to ... acquired by Hypermarcas). Together, these transactions will provide Amgen ...
... the leading health care supply contracting company, announced today ... to its portfolio of agreements for Cardiac Rhythm Management ... leading provider of medical devices which treat cardiac, neurological ... portfolio of arrhythmia management products, including pacemakers, implantable cardioverter ...
Cached Medicine Technology:Amgen Establishes Commercial Operations in Brazil 2Amgen Establishes Commercial Operations in Brazil 3Amgen Establishes Commercial Operations in Brazil 4Novation Announces the Addition of St. Jude Medical to the Cardiac Rhythm Management Products Portfolio 2
Bambi database allows images, analytical results, and eyebank or clinical information to be stored in an easy-to-access database. In most cases, the analytical results from any of our analysis progra...
This computerized retail software is aimed for opticians/optometrists, optical chains/1 hr superstores, optical HMOs, and ophthalmology groups....
... marketing software enables the efficient capture of ... also has many built-in time saving and ... of name fields and numerous user definable ... data input. The pre-defined options in the ...
... management software for eyecare professionals- ... multi-tasking, multi-office practice management system, ... technology- Winx Pro is a ... you in effectively managing the ...
Medicine Products: